Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy

Ken Kamata; Mamoru Takenaka; Naoshi Nishida; Akane Hara; Yasuo Otsuka; Hidekazu Tanaka; Shunsuke Omoto; Kosuke Minaga; Kentaro Yamao; Yasutaka Chiba; Kazuko Sakai; Kazuto Nishio; Tomohiro Watanabe; Masatoshi Kudo

doi:10.1007/s10147-023-02396-w

Related publications

Article2016

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Erika Vacchelli, David Enot, Federico Pietrocola, Laurence Zitvogel, Guido Guido Kroemer

Article2018

Diagnostic and prognostic value of KRAS mutations in circulating pancreatic ductal adenocarcinoma tumor DNA

Xin-she Yang, Wei Xu, Xiuyun Tian, Jianhui Wu, Ang Lv, Chengpeng Li, Xiaoya Guan, Hong-Gang Qian, Chunyi Hao

Translational Cancer Research

Article2018

Metabolomics analysis of pancreatic juice indicates an alteration in glucose metabolism in pancreatic ductal adenocarcinoma patients

Nina Cortese, Giovanni Francesco Castino, Giovanni Capretti, Panteleimon G. Takis, Francesca Gavazzi, Cristina Ridolfi, Gennaro Nappo, Giulia Maggi, Paola Allavena, Alberto Mantovani, Alessandro Zerbi, Federica Marchesi

Article2010

Stat3 and MMP7 mediate multiple aspects of pancreatic ductal adenocarcinoma biology

Sam C. Wang, Akihisa Fukuda, John P. Morris, Angela Liou, Akira Shizuo, Matthias Hebrok

Journal of the American College of Surgeons

Article2011

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Eric A. Collisson, Anguraj Sadanandam, Peter Olson, William J. Gibb, Morgan Truitt, Shenda Gu, J. Cooc, Jennifer Weinkle, Grace Kim, Lakshmi R. Jakkula, Heidi S. Feiler, Andrew H. Ko, Adam B. Olshen, Kathleen L Danenberg, Margaret A. Tempero, Paul T. Spellman, Douglas Hanahan, Joe W. Gray